Prevalence and determinants of psychotropic medication use in Poland.

IF 0.9 4区 医学 Q4 PSYCHIATRY
Agnieszka Pisarska, Jakub Stokwiszewski, Jacek Moskalewicz
{"title":"Prevalence and determinants of psychotropic medication use in Poland.","authors":"Agnieszka Pisarska, Jakub Stokwiszewski, Jacek Moskalewicz","doi":"10.12740/PP/OnlineFirst/159734","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the study was to assess the prevalence of psychotropic medication use among adult population in Poland in past 12 months, and to analyse the relationship between psychotropic medication use and sociodemographic factors as well as mental health disorders experienced by respondents.</p><p><strong>Methods: </strong>Composite International Diagnostic Instrument (WHO CIDI 3.0) was used in Polish survey of general population aged 18-64. Respondents were randomly selected from the population register. Ten thousand interviews were completed with a response rate of 50,4%.</p><p><strong>Results: </strong>In the general population, psychotropic medicines were used by almost 5% of the respondents in the past 12 months. These medicines were used more often by women, respondents from the oldest age group, with low level of education, retirees, unemployed, singles and residents of small and large cities. Among those experiencing mental health problems in the past 12 months, psychotropic medications were taken by up to 17% of the respondents. Pharmacological treatment was most often endorsed by over 40% of persons with symptoms of major depression and any mood disorders, while approximately 25% of respondents with major depression confirmed antidepressant use. Gender differences were small and mostly insignificant.</p><p><strong>Conclusions: </strong>The results indicate the need to improve access to mental health treatment and to educate better general practitioners (GPs) for appropriate diagnosing and treatment of mental health disorders.</p>","PeriodicalId":20863,"journal":{"name":"Psychiatria polska","volume":" ","pages":"619-636"},"PeriodicalIF":0.9000,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatria polska","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12740/PP/OnlineFirst/159734","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The aim of the study was to assess the prevalence of psychotropic medication use among adult population in Poland in past 12 months, and to analyse the relationship between psychotropic medication use and sociodemographic factors as well as mental health disorders experienced by respondents.

Methods: Composite International Diagnostic Instrument (WHO CIDI 3.0) was used in Polish survey of general population aged 18-64. Respondents were randomly selected from the population register. Ten thousand interviews were completed with a response rate of 50,4%.

Results: In the general population, psychotropic medicines were used by almost 5% of the respondents in the past 12 months. These medicines were used more often by women, respondents from the oldest age group, with low level of education, retirees, unemployed, singles and residents of small and large cities. Among those experiencing mental health problems in the past 12 months, psychotropic medications were taken by up to 17% of the respondents. Pharmacological treatment was most often endorsed by over 40% of persons with symptoms of major depression and any mood disorders, while approximately 25% of respondents with major depression confirmed antidepressant use. Gender differences were small and mostly insignificant.

Conclusions: The results indicate the need to improve access to mental health treatment and to educate better general practitioners (GPs) for appropriate diagnosing and treatment of mental health disorders.

波兰精神药物使用的普遍性和决定因素。
研究目的研究旨在评估波兰成年人在过去 12 个月中使用精神药物的情况,并分析精神药物的使用与社会人口因素以及受访者所经历的心理健康障碍之间的关系:方法:在波兰对 18-64 岁的普通人群进行的调查中使用了《国际综合诊断工具》(WHO CIDI 3.0)。受访者从人口登记册中随机抽取。共完成了 1 万次访谈,回复率为 50.4%:在普通人群中,近 5%的受访者在过去 12 个月中使用过精神药物。女性、年龄最大的受访者、受教育程度较低、退休人员、失业人员、单身人士以及大中小城市的居民更经常使用这些药物。在过去 12 个月中出现过精神健康问题的受访者中,服用精神药物的比例高达 17%。超过 40% 有重度抑郁症状和任何情绪障碍的受访者最常认可药物治疗,而约 25% 有重度抑郁症状的受访者确认服用过抗抑郁药物。性别差异很小,而且大多不明显:结果表明,有必要改善心理健康治疗的可及性,并对全科医生(GPs)进行更好的教育,以便对心理健康疾病进行适当的诊断和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychiatria polska
Psychiatria polska 医学-精神病学
CiteScore
2.30
自引率
23.50%
发文量
92
审稿时长
6-12 weeks
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信